Hyman B. Muss, MD, is an experienced clinician-scientist, the Mary Jones Hudson Distinguished Professor of Geriatric Oncology at the University of North Carolina School of Medicine, and the Director of the Geriatric Oncology Program at the UNC Lineberger Comprehensive Cancer Center Program.
As an internationally recognized leader in education and research focused on cancer in older patients, Dr. Muss’s professional interests center on the research and care of older women with breast cancer, breast cancer survivorship, and long-term toxicity of treatment.
After working with his previous UNC colleague, Dr. Ned Sharpless, Dr. Muss is investigating the role of biomarkers of aging and their potential role as predictors of toxicity and survival. In addition to developing and serving as the PI of multiple clinical and translational trials, he was the lead author of the NCI-sponsored intergroup trial that compared standard care with oral chemotherapy in older women with early-stage breast cancer, which for the first time, showed the value of chemotherapy in this older population.
He serves as the mentor for medical students, residents, junior faculty, and more recently Geriatric Oncology fellows. He previously co-chaired the Alliance Committee on Cancer in Older Adults. He has been co-chair of the Breast Committee for the CALGB, Chair and a member of the board of Directors of the American Board of Internal Medicine, and a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and the ASCO Foundation. He was awarded the B.J. Kennedy Award in Geriatric Oncology by ASCO, the Susan G. Komen for the Cure Brinker Award for Scientific Distinction in Clinical Research, and an honorary Doctor of Science Degree from his alma mater, Lafayette College. He served in the U.S. Army in Vietnam where he was awarded the Bronze Star medal.